One-glance verdict
$80.27 our estimate vs market $152.31
Wall Street consensus: $247.40 (208.2% higher than our fair-value estimate)
90% above our estimate, beyond the bull case
Fundamentals snapshot
LEU · NYQ · Energy · Uranium
Current price
$152.31
52-week range
$142.13 - $464.25
Market cap
$3.12B
One-glance verdict
Wall Street consensus: $247.40 (208.2% higher than our fair-value estimate)
90% above our estimate, beyond the bull case
Balance sheet
Net cash $691.00M. Interest coverage shows how many times profit covers the interest bill.
What stands out
What this company does
Centrus Energy is a key supplier of enriched uranium, which is the special fuel needed to power nuclear reactors. The company makes most of its money selling this fuel to the utility companies that operate power plants in the U.S. and around the world. As one of the few domestic producers, Centrus is an important part of the energy supply chain (the entire process of creating and distributing a product), which is vital for national energy security.
Centrus Energy began as a government-owned entity called the United States Enrichment Corporation (USEC), created in 1992 to take over the U.S. government's uranium enrichment program, which had been running since the 1940s. In 1998, the government sold it to the public, and it became a private company. A major turning point was its role in the "Megatons to Megawatts" program, which converted uranium from old Soviet nuclear warheads into fuel for power plants. After facing financial difficulties, the company restructured and re-emerged in 2014 with its current name, Centrus Energy Corp.
Think of Centrus Energy as a specialized fuel supplier for the nuclear power industry. Just as a car needs gasoline, nuclear power plants need uranium to generate electricity. Centrus doesn't mine the uranium from the ground, but it takes a form of uranium and enriches it, a process that makes it usable as fuel. It then sells this enriched uranium to utility companies that operate nuclear power plants in the U.S. and around the world.
This is the company's main business, making up the majority of its sales. This segment is like a fuel brokerage; it sells low-enriched uranium (LEU), the standard fuel for most existing nuclear power plants, to utility companies. Centrus secures this fuel through long-term supply contracts with various producers and then sells it to the power plant operators. The revenue (money the company makes from sales) from this segment comes from these fuel sales to utilities.
This is a smaller but growing part of the company that focuses on advanced technology and services. Think of it as the research and development arm that also provides expert consulting. This segment works on contracts, often with the U.S. government, to develop new types of nuclear fuel and provide engineering and manufacturing services. A key product here is High-Assay, Low-Enriched Uranium (HALEU), a more advanced fuel needed for many next-generation nuclear reactors.
The company is heavily focused on becoming a key American producer of nuclear fuel to ensure the country isn't dependent on other nations. A major part of this strategy is expanding its production of High-Assay, Low-Enriched Uranium (HALEU), the fuel required for many new, advanced nuclear reactor designs. By building up its enrichment plant in Ohio, Centrus aims to supply both the next generation of commercial power plants and meet U.S. national security needs. This positions them to capitalize on the growing interest in nuclear power as a source of clean energy.
Price history
Earnings history
Click any quarter to read the call summary and what the numbers say.
Is it cheap or expensive?
Wall Street consensus is the average analyst price target: $247.40 (208.2% higher than our fair-value estimate).
Our most-likely fair value is $80.27 a share — about 47.3% below today's price of $152.31, so the stock currently looks expensive (overvalued).
Is it drowning in debt?
Net cash $691.0M - more cash than debt. Interest coverage 3.6x.
Centrus Energy Corp.'s profit covers its interest bill about 3.6 times over. which is stronger than most peers shown here and 3 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.
Total debt $1.18B Interest coverage 3.59x This is the baseline the peer rows are being compared against.
Total debt $880.64M Interest coverage 6.49x +81% vs LEU Carries about 1.8x more debt cushion than LEU.
Total debt $1.91M Interest coverage -50.78x -100% vs LEU This peer has almost no interest-payment cushion compared with LEU.
Total debt $678.34M Interest coverage -609.37x -100% vs LEU This peer has almost no interest-payment cushion compared with LEU.
Total debt $446.23M Interest coverage -1.92x -100% vs LEU This peer has almost no interest-payment cushion compared with LEU.
Total debt $2.02B Interest coverage 7.34x +105% vs LEU Carries about 2.0x more debt cushion than LEU.
What you should know
The numbers
Tap any ? icon to learn what it means.
Valuation
Profitability
Health
Growth
Cash flow
Dividend
Metric explainer
Debt comparison
What you should know